NO20070665L - Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer - Google Patents
Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommerInfo
- Publication number
- NO20070665L NO20070665L NO20070665A NO20070665A NO20070665L NO 20070665 L NO20070665 L NO 20070665L NO 20070665 A NO20070665 A NO 20070665A NO 20070665 A NO20070665 A NO 20070665A NO 20070665 L NO20070665 L NO 20070665L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- neurodegenerative diseases
- derivatives
- phenylalkanecarboxylic
- phenylalkanecarboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Den foreliggende oppfinnelsen vedrører nye derivater av 1-fenylalkankarboksylsyre, farmasøytiske blandinger av denne, en fremgangsmåte for deres fremstilling og deres bruk i behandlingen og/eller forebyggingen av nevrodegenerative sykdommer så som Alzheimers sykdom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04425604 | 2004-08-03 | ||
PCT/IB2005/002189 WO2006016219A2 (en) | 2004-08-03 | 2005-07-26 | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20070665L true NO20070665L (no) | 2007-05-02 |
NO339921B1 NO339921B1 (no) | 2017-02-13 |
Family
ID=35462580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070665A NO339921B1 (no) | 2004-08-03 | 2007-01-31 | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer |
Country Status (22)
Country | Link |
---|---|
US (1) | US7531692B2 (no) |
EP (1) | EP1778623B1 (no) |
JP (1) | JP4866851B2 (no) |
KR (1) | KR101156393B1 (no) |
CN (1) | CN1984878B (no) |
AT (1) | ATE399758T1 (no) |
AU (1) | AU2005270949B2 (no) |
BR (1) | BRPI0513647A (no) |
CA (1) | CA2576009C (no) |
CY (1) | CY1110401T1 (no) |
DE (1) | DE602005007912D1 (no) |
DK (1) | DK1778623T3 (no) |
ES (1) | ES2309778T3 (no) |
HK (1) | HK1104280A1 (no) |
HR (1) | HRP20080494T3 (no) |
NO (1) | NO339921B1 (no) |
PL (1) | PL1778623T3 (no) |
PT (1) | PT1778623E (no) |
RS (1) | RS50601B (no) |
SI (1) | SI1778623T1 (no) |
WO (1) | WO2006016219A2 (no) |
ZA (1) | ZA200700945B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004074232A1 (en) * | 2003-02-21 | 2004-09-02 | Chiesi Farmaceutici S.P.A. | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
BR112012026803A2 (pt) | 2010-04-21 | 2016-07-12 | Chiesi Farma Spa | composto |
WO2011151330A1 (en) | 2010-06-04 | 2011-12-08 | Chiesi Farmaceutici S.P.A. | 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases |
US9592210B2 (en) | 2011-12-22 | 2017-03-14 | Chiesi Farmaceutici S.P.A. | 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment |
EP2834214A1 (en) | 2012-04-04 | 2015-02-11 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases |
WO2015181094A1 (en) | 2014-05-26 | 2015-12-03 | Chiesi Farmaceutici S.P.A. | 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome |
US11498904B2 (en) | 2017-11-14 | 2022-11-15 | Merck Sharp & Dohme Llc | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
US10647705B2 (en) | 2017-11-14 | 2020-05-12 | Merck Sharp & Dohme Corp. | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
US6211235B1 (en) * | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6117901A (en) * | 1996-11-22 | 2000-09-12 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use |
US6191166B1 (en) * | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
CA2279977A1 (en) * | 1997-02-04 | 1998-08-06 | John S. Kiely | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
US5994379A (en) * | 1998-02-13 | 1999-11-30 | Merck Frosst Canada, Inc. | Bisaryl COX-2 inhibiting compounds, compositions and methods of use |
FR2842523A1 (fr) * | 2002-07-17 | 2004-01-23 | Sanofi Synthelabo | Derives d'acylaminothiazole, leur preparation et leur application en therapeutique |
WO2004074232A1 (en) | 2003-02-21 | 2004-09-02 | Chiesi Farmaceutici S.P.A. | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
-
2005
- 2005-07-26 AU AU2005270949A patent/AU2005270949B2/en not_active Ceased
- 2005-07-26 CA CA2576009A patent/CA2576009C/en not_active Expired - Fee Related
- 2005-07-26 EP EP05767873A patent/EP1778623B1/en active Active
- 2005-07-26 ZA ZA200700945A patent/ZA200700945B/xx unknown
- 2005-07-26 KR KR1020067027604A patent/KR101156393B1/ko not_active IP Right Cessation
- 2005-07-26 SI SI200530328T patent/SI1778623T1/sl unknown
- 2005-07-26 PT PT05767873T patent/PT1778623E/pt unknown
- 2005-07-26 AT AT05767873T patent/ATE399758T1/de active
- 2005-07-26 US US11/572,974 patent/US7531692B2/en not_active Expired - Fee Related
- 2005-07-26 ES ES05767873T patent/ES2309778T3/es active Active
- 2005-07-26 DE DE602005007912T patent/DE602005007912D1/de active Active
- 2005-07-26 JP JP2007524411A patent/JP4866851B2/ja not_active Expired - Fee Related
- 2005-07-26 BR BRPI0513647-4A patent/BRPI0513647A/pt not_active IP Right Cessation
- 2005-07-26 WO PCT/IB2005/002189 patent/WO2006016219A2/en active Application Filing
- 2005-07-26 RS RSP-2008/0392A patent/RS50601B/sr unknown
- 2005-07-26 DK DK05767873T patent/DK1778623T3/da active
- 2005-07-26 PL PL05767873T patent/PL1778623T3/pl unknown
- 2005-07-26 CN CN200580023905XA patent/CN1984878B/zh not_active Expired - Fee Related
-
2007
- 2007-01-31 NO NO20070665A patent/NO339921B1/no not_active IP Right Cessation
- 2007-08-28 HK HK07109391.9A patent/HK1104280A1/xx not_active IP Right Cessation
-
2008
- 2008-09-04 CY CY20081100961T patent/CY1110401T1/el unknown
- 2008-10-01 HR HR20080494T patent/HRP20080494T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1984878A (zh) | 2007-06-20 |
JP2008509124A (ja) | 2008-03-27 |
SI1778623T1 (sl) | 2008-10-31 |
EP1778623B1 (en) | 2008-07-02 |
CN1984878B (zh) | 2011-06-08 |
KR20070038982A (ko) | 2007-04-11 |
NO339921B1 (no) | 2017-02-13 |
PT1778623E (pt) | 2008-09-29 |
ES2309778T3 (es) | 2008-12-16 |
DE602005007912D1 (de) | 2008-08-14 |
PL1778623T3 (pl) | 2008-12-31 |
HK1104280A1 (en) | 2008-01-11 |
CA2576009C (en) | 2013-02-26 |
AU2005270949B2 (en) | 2011-02-03 |
CY1110401T1 (el) | 2015-04-29 |
JP4866851B2 (ja) | 2012-02-01 |
HRP20080494T3 (en) | 2008-11-30 |
AU2005270949A1 (en) | 2006-02-16 |
ZA200700945B (en) | 2008-09-25 |
KR101156393B1 (ko) | 2012-06-13 |
ATE399758T1 (de) | 2008-07-15 |
WO2006016219A2 (en) | 2006-02-16 |
DK1778623T3 (da) | 2008-10-20 |
CA2576009A1 (en) | 2006-02-16 |
US7531692B2 (en) | 2009-05-12 |
BRPI0513647A (pt) | 2008-05-13 |
WO2006016219A3 (en) | 2006-04-27 |
US20080096968A1 (en) | 2008-04-24 |
RS50601B (sr) | 2010-05-07 |
EP1778623A2 (en) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
NO20053855D0 (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
MX2009005279A (es) | Derivados de n-(metil)-1h-pirazol-3-amina, n-(metil)-piridin-2-ami na y n-(metil)-tiazol-2-amina para el tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide, tal como por ejemplo alzheimer. | |
EP1784388B8 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
NO20054769L (no) | Substituerte fenylalkansyrer | |
NO20050701L (no) | 4-pyrrolidino-fenyl-benzyleter derivater | |
HUP0204182A2 (hu) | Fumársavszármazékok használata mitokondriális betegségek kezelésére | |
BR0315158A (pt) | Compostos de pirazol para o tratamento de distúrbios neurodegenarativos | |
NO20090328L (no) | Nye forbindelser 385 | |
NO20081843L (no) | Farmasoytisk sammensetning for forbedret kognitiv funksjon | |
NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit | |
NO20061290L (no) | Nye forbindelser | |
NO20090812L (no) | Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser | |
BRPI0509881A (pt) | combinação terapêutica para tratamento da doença de alzheimer | |
BRPI0704074B8 (pt) | derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação | |
WO2007019111A3 (en) | Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease | |
UA111587C2 (uk) | Сполуки для лікування захворювань, пов'язаних з амілоїдними або амілоїдоподібними білками |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |